A 10321 New York Assembly · 2017 Regular Session

Establishes a schedule VI of drugs and other substances; includes gabapentin as a drug to be monitored through the prescription monitoring program

Summary
Establishes a schedule VI of drugs and other substances; includes gabapentin as a drug to be monitored through the prescription monitoring program; makes conforming changes; and directs the commissioner of health to promulgate regulations necessary or desirable to classify gabapentin and its chemical equivalents as a scheduled substance for the purposes of article 33 of the public health law.
Bill status in committee 1 of 4 stages cleared
Introduction
Apr 2018
Committee Review
Floor Vote
Governor
Introduced Apr 10, 2018 Last action Apr 10, 2018
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
1
Key actions
0
Committee
1
Apr 10, 2018
Legislature · Referred to committee
REFERRED TO HEALTH
0 primary · 0 co-sponsors

Sponsors

No sponsor information available.